Task: Answer the multiple choice question.
Query: Which drug exhibits a -15.469% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CC(OC(=O)c1ccncc1)C(=O)Nc1cc(S(=O)(=O)N2CCCCC2)ccc1Cl
[b] CC(=O)c1cccc(NC(=O)N2C3CCC2CC(NC(=O)C2CC2)C3)c1
Answer: a. CC(OC(=O)c1ccncc1)C(=O)Nc1cc(S(=O)(=O)N2CCCCC2)ccc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(OC(=O)c1ccncc1)C(=O)Nc1cc(S(=O)(=O)N2CCCCC2)ccc1Cl
CC(OC(=O)c1ccncc1)C(=O)Nc1cc(S(=O)(=O)N2CCCCC2)ccc1Cl
[1-(2-chloro-5-piperidin-1-ylsulfonylanilino)-1-oxopropan-2-yl]pyridine-4-carboxylate